全球单纯疱疹病毒 (HSV) 检测市场 – 行业趋势和 2029 年预测

市场分析和规模

近几十年来，由于重大技术突破和医疗保健业务需求的不断增长，单纯疱疹病毒 (HSV) 检测分析仪越来越受欢迎。单纯疱疹病毒 (HSV) 检测侧重于检查体内体液，并提供精确的诊断信息。现代单纯疱疹病毒 (HSV) 检测建立在传统手动实验室检测的基础上。然而，随着技术的进步，检测方法也得到了发展，现在可以使用化学分析仪等复杂设备在自动化实验室中进行各种检测。

Data Bridge Market Research 分析，单纯疱疹病毒 (HSV) 检测市场规模在 2021 年为 23.2 亿美元，到 2029 年将飙升至 29.6 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 3.10%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分      

Market Definition

The contagious herpes simplex virus (HSV) can spread through saliva, sperm, and vaginal secretions, resulting in painful blisters or ulcers. Blood testing, fluid collection, and physical examinations are typically used to diagnose it. Currently, the best available treatments for patients are antiviral drugs like famciclovir, acyclovir, and valacyclovir. These drugs can be taken orally or intravenously (IV) to help with symptom relief, lessen the frequency and intensity of outbreaks, and stop the virus from spreading.

Herpes Simplex Virus (HSV) Testing Market Dynamics

Drivers

• Rising number of patients with the herpes simplex virus

In the forecast period of 2022–2029, factors such as the rate of new infections, the expansion of clinical research, and technological advancements are projected to boost the growth of the herpes simplex virus (HSV) testing market. However, the development of accurate screening tests and the expansion of the healthcare industry will create additional growth prospects for the herpes simplex virus (HSV) testing market throughout the forecast period.

• Rising prevalence of chronic disorders

HSV can cause serious side effects like encephalitis and keratitis in those with long-term or chronic conditions and increase the chance of contracting and transmitting the HIV infection. This is one of the key factors influencing the need for HSV therapy around the world. Moreover, when an infant is exposed to HSV in the vaginal tract during birth, neonatal herpes, a dangerous illness, may develop. The market is benefiting from the increased birth rate because neonatal herpes can result in long-term neurologic impairment or baby death.

• Increased prevalence of hospital-acquired infections

Herpes simplex virus treatment demand is primarily driven by the increased prevalence of hospital-acquired infections and low immunity disorders due to the abrupt global spread of the COVID-19 pandemic. Furthermore, HSV can cause serious difficulties in people with long-term or chronic illnesses, such as keratitis and encephalitis, increasing the risk of transmission and acquisition of the human immunodeficiency virus (HIV) disease further driving the market's expansion.

Opportunities

The market is expanding as a result of increased research and development activity. Due to the significant financial burden that herpes simplex virus infections place on healthcare systems worldwide, there is a high potential for growth in the market for herpes simplex virus treatments. Over the forecast period, this market is anticipated to grow at a faster rate than average.

Restraints/Challenges

Limited availability of laboratories along with lack of skilled personnel are acting as market restraints for the growth of the herpes simplex virus (HSV) testing in the above mentioned forecast period. However, one of the main barriers to the market's expansion is the social stigma attached to sexually transmitted illnesses, compounded by increased product recalls.

This herpes simplex virus (HSV) testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the herpes simplex virus (HSV) testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Herpes Simplex Virus (HSV) Testing Market

The COVID-19 pandemic had a major effect on market expansion. The researcher established the link between the herpes simplex virus and the SARS-CoV-2 virus in numerous studies, which positively affected the market by increasing demand for antiviral medications for treatment. The COVID-19 and its effects on those with the herpes simplex virus are also predicted to fuel market growth (HSV). The odds ratio for the prevalence of the herpes simplex virus type-1 in the COVID-19 group was 5.27, while it was 2.81 percent in the hospital population. As a result, the ongoing epidemic increased demand for herpes simplex virus treatments. However, the COVID-19 pandemic disrupted the development of various treatments and medications for illnesses other than COVID-19 and had an influence on global pharmaceutical supply chains and treatment protocols, which in turn had an impact on the market for treating herpes simplex virus.

Recent Development

• In October 2021, United BioPharma collaborated with the Shanghai Public Health Clinical Centre and the Department of Microbiology and Immunology at Cheng Kung University to study the efficacy of UB-621, a best-in-class long-acting medication for genital herpes caused by simplex viruses 1 and 2. (HSV 1 and HSV2).
• 2021 年 7 月，AiCuris Anti-infective Cures AG 开始对新型解旋酶-引发酶抑制剂 pritelivir 进行 III 期开发，用于治疗免疫功能低下患者的阿昔洛韦耐药粘膜皮肤单纯疱疹病毒 (HSV) 感染。

全球单纯疱疹病毒 (HSV) 检测市场范围

单纯疱疹病毒 (HSV) 检测市场根据类型、应用、适应症和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

类型

• 抗体/抗原试剂盒
• 病毒培养检测试剂盒
• 基于核酸扩增的试剂盒
• 其他

 终端用户

• 诊断中心
• 医院
• 家庭使用
• 其他

 应用

• 研究用途
• 临床诊断

 指征

• 单纯疱疹病毒-1
• 单纯疱疹病毒-2
• 单纯疱疹病毒-1/单纯疱疹病毒-2

单纯疱疹病毒 (HSV) 检测市场区域分析/见解

对单纯疱疹病毒 (HSV) 检测市场进行了分析，并按国家、类型、应用、适应症和最终用户提供了市场规模洞察和趋势，如上所述。

单纯疱疹病毒 (HSV) 检测市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于临床研究数量的增加和医疗保健基础设施的普及率的提高，北美在单纯疱疹病毒 (HSV) 检测市场占据主导地位。

由于人们健康意识的增强和对先进医疗技术的需求不断增加，预计亚太地区将在 2022 年至 2029 年的预测期内以最高的增长率增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和单纯疱疹病毒 (HSV) 检测市场份额分析

单纯疱疹病毒 (HSV) 检测市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对单纯疱疹病毒 (HSV) 检测市场的关注有关。

单纯疱疹病毒 (HSV) 检测市场的一些主要参与者包括：

• 雅培（美国）
• Abcam plc.（英国）
• 生物梅里埃（法国）
• 赛默飞世尔科技公司（美国）
• F. Hoffmann-La Roche Ltd（瑞士）
• DiaSorin SpA（意大利）
• Quidel Corporation（美国）
• Luminex 公司（美国）
• 默克集团（德国）
• QIAGEN（德国）
• Norgen Biotek Corp.（加拿大）
• Hologic Inc.（美国）
• Bio-Rad Laboratories, Inc.（美国）
• Meridian Bioscience, Inc.（美国）
• Teco Diagnostics（美国）
• 葛兰素史克公司（英国）
• Agenus Inc.（美国）
• 丸丰株式会社（日本）
• 赛诺菲（法国）

SKU-56699